Pharmaceutical industry – Page 46

Opinion
Cut price pills cost more than pennies

2013-12-19T00:00:00Z

We can’t afford to let the demand for cheaper medicines force compromises on quality, says Steven Ford
Business
Celgene buys into anticancer antibodies

2013-12-04T00:00:00Z

Partners with OncoMed in a deal worth up to $3.3bn
Business
New wave of hepatitis C drugs hits US shore

2013-12-03T00:00:00Z

J&J’s once-daily drug approved by FDA, but rivals are hot on its heels
Business
US turnaround on Avandia restrictions

2013-12-02T00:00:00Z

Researchers accuse regulator of face-saving U-turn over diabetes medication safety
Opinion
Put the chemistry back in medicinal chemistry

2013-11-28T00:00:00Z

Pursuing skewed priorities and easy options has impoverished the pharmaceutical industry, says David Lathbury.
Opinion
Rolling boulders uphill

2013-11-27T00:00:00Z

Is Derek Lowe troubled by his failure to develop a compound that has made it to the pharmacy shelf?
Business
Regulator cracks down on 23andMe

2013-11-26T00:00:00Z

Personal genetic profiler ordered to stop selling DNA test kits
Business
Pfizer teams up with GSK in cancer drug trial

2013-11-25T00:00:00Z

Two companies will collaborate to develop a combination therapy for melanoma
Feature
Generic problems

2013-11-22T00:00:00Z

The Indian pharmaceutical industry has been hit by recent problems. Angeli Mehta investigates
Business
DSM to spin out pharma unit

2013-11-22T00:00:00Z

Firm will combine with Patheon to provide manufacturing services
Business
Novartis sells off blood diagnostics division

2013-11-14T00:00:00Z

$1.7bn deal reinforces firm’s focus on core pharmaceuticals
Careers
The pain killer

2013-11-13T00:00:00Z

Life is pretty painless working in Reckitt Benckiser’s Nurofen team, Sarah Houlton learns
Business
Shire will cut UK R&D to focus on rare diseases

2013-11-11T00:00:00Z

$4.2bn buyout of ViroPharma bolsters pipeline, while Basingstoke site halts research
Business
Mis-selling lands J&J with $2.2bn fine

2013-11-11T00:00:00Z

Company found guilty of promoting three drugs for unapproved uses
Business
Novartis to shut Horsham site

2013-11-06T00:00:00Z

UK research centre closure to result in the loss of 371 jobs as firm consolidates its global R&D base
Opinion
Natural born chemists

2013-10-31T00:00:00Z

Redesigning nature’s catalysts is tantalising but tricky, says Derek Lowe
Business
Vertex to cut 370 jobs

2013-10-30T00:00:00Z

Imminent competition drives drop in its hepatitis C drug’s performance
Business
AstraZeneca to close environmental lab and cut 71 jobs

2013-10-25T00:00:00Z

Environmental impact services will be outsourced after Devon lab closes in March 2014
Business
Pharma manufacturing woes dog industry

2013-10-23T00:00:00Z

Regulators are stepping up inspections, and discovering ever more problems
Business
Counterfeit anxiety pills seized in Switzerland

2013-10-21T00:00:00Z

1 million fake tablets were en route from China to Egypt